Koa Shoji Holdings Co.,Ltd. (TYO:9273)

Market Cap	33.74B
Revenue (ttm)	23.27B
Net Income (ttm)	3.64B
Shares Out	42.12M
EPS (ttm)	86.35
PE Ratio	9.28
Forward PE	n/a
Dividend	17.00 (2.12%)
Ex-Dividend Date	Jun 27, 2025

Volume	36,800
Average Volume	49,670
Open	802.00
Previous Close	801.00
Day's Range	791.00 - 807.00
52-Week Range	570.00 - 839.00
Beta	0.67
RSI	50.43
Earnings Date	Nov 7, 2025

About Koa Shoji Holdings

Koa Shoji Holdings Co.,Ltd., through its subsidiaries, imports and sells active pharmaceutical ingredients (APIs) in Japan. The company is involved in the manufacture and marketing of OTC drugs and health foods; primarily various vitamins; and manufacture and sale of generic APIs and drugs, as well as pharmaceuticals comprising injections. It also engages in contract manufacturing of pharmaceuticals; packaging of pharmaceutical products; and purchase and sale of pharmaceuticals. Koa Shoji Holdings Co.,Ltd. was founded in 1991 and is headquarter...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 304
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 9273

Financial Performance

In 2025, Koa Shoji Holdings's revenue was 23.27 billion, an increase of 5.13% compared to the previous year's 22.13 billion. Earnings were 3.64 billion, an increase of 23.46%.